Artificial intelligence is already saving lives in healthcare. That part is no longer up for debate.
What is holding us back is not the technology. It is HIPAA and the way we interpret healthcare privacy in a world that no longer resembles the one these laws were written for.
HIPAA was created to protect patients from exposure and misuse of their personal medical information. That goal still matters. But the unintended consequence is that we have built a system where healthcare data is treated as untouchable property rather than as a resource that could save lives at scale.
The result is a healthcare system drowning in data that it refuses to learn from.
And the frustrating part is this: we are not saying no to anonymized health data. We are just endlessly not doing it.
That delay is the problem.
What Anonymizing Healthcare Data Actually Means
Before anything else, this needs to be crystal clear.
Anonymizing healthcare data does not mean exposing patient identities. It does not mean sharing personal medical records. It does not mean anyone can look up your health history.
It means stripping away anything that identifies a person while preserving what matters most: patterns.
Patterns across:
- Symptoms and outcomes
- Disease progression
- Genetics and environment
- Treatments and long-term results
- What worked, what failed, and why
Modern anonymization techniques already exist to prevent reidentification while maintaining medical accuracy. This is not experimental. It is not reckless. It is already done in limited research settings.
What we do not have is scale.
Right now, data lives in silos. Hospitals see only their own patients. Researchers fight for access. AI models train on incomplete, biased, and narrow datasets.
We are trying to solve humanity’s hardest medical problems while refusing to look at humanity as a whole.
People Are Afraid of Getting Care From Computers, But That Is Not What This Is
A major unspoken fear is that people do not want their healthcare delivered by a computer.
That fear is understandable. But it misses the reality of how AI actually improves care.
The best outcomes happen when AI works with the doctor, supplementing judgment and suggesting questions, diagnoses, and treatments the physician may not have considered. AI can widen the clinical “search space” in real time, while the physician brings context, ethics, and accountability that a system never should carry alone.
This is not about replacing clinicians. It is about giving them a stronger set of tools, so fewer things are missed and more patients get the right care sooner.
What This Would Do to Healthcare Data and Medical Research
The most immediate and transformative impact of anonymized healthcare data would be on research.
Today, medical research is constrained less by talent or funding and more by access. Researchers spend years navigating approvals, negotiating data use agreements, and working with datasets that are too small, too narrow, or too short-lived to answer the questions that actually matter.
Anonymizing healthcare data at scale would remove this bottleneck almost overnight.
Research Would Stop Starting From Scratch
Instead of building studies on thousands of patients, researchers could validate findings across millions. Hypotheses could be tested against real-world outcomes quickly, rather than waiting years for replication.
Longitudinal Insight Would Replace Snapshot Studies
Researchers could track how diseases develop, how treatments perform, and what consequences appear years later without ever knowing who the patients are. The ability to learn over time, rather than in isolated moments, would fundamentally change how medicine advances.
Rare Diseases Would Stop Being Invisible
What is rare to a single hospital becomes visible at population scale. Patterns emerge. Diagnostic delays shrink. Families stop waiting years for answers.
Failure Would Finally Teach Us Faster
Failed treatments, negative outcomes, and rare side effects are often buried or forgotten. With anonymized population data, failure becomes as valuable as success. Dead ends can be identified earlier, saving time, money, and lives.
Research Would Become More Equitable
Today’s studies are often biased toward populations that are easiest to reach. Population-scale data would bring visibility to underrepresented groups and lead to fairer, more effective medicine for everyone.
None of this requires a scientific breakthrough. The infrastructure already exists. What is missing is the decision to treat anonymized healthcare data as shared research infrastructure instead of locked private property.
Clinical Trials Would Be Revolutionized
The current gold standard for evaluating a new treatment is the randomized, prospective, double blind clinical trial. This model minimizes known and unknown differences and biases between treatment and control groups. Patients and their doctors generally do not know whether the patient is receiving the new treatment or is in the control group.
The problem is that such trials generally require hundreds to thousands of consenting patients and can take many years. As a result, a new drug often takes 10 to 15 years from discovery to FDA approval.
With AI and anonymized population health data, clinical research can be dramatically shortened.
- New treatments could be compared to hundreds of thousands of existing control patients.
- Variables between groups could be reduced dramatically through scale and better matching.
- Efficacy signals could be identified in months to a few years rather than a decade or more.
- Patients seeking a new treatment would not face the risk of “randomly” receiving the control therapy when they are hoping for the new option.
This does not eliminate the need for rigorous trials. It changes how quickly we learn, how intelligently we design trials, and how many dead ends we can avoid.
Drug Discovery Would Get Faster and We Would Learn More From Existing Drugs
Drug companies generally choose the “easiest” clinical indication of a new drug to evaluate in a clinical trial. Other potentially important things the drug does may only later, or never, be discovered.
For example, Ozempic was initially approved as a diabetes drug. It was only later that its effect on weight loss became widely recognized.
With AI analyzing large-scale anonymized health data, these additional effects could be identified earlier and evaluated more clearly.
Even more importantly, drugs and treatments already in use could be extensively evaluated for rare side effects and potential new benefits.
Metformin, a very old diabetes drug, may have the remarkable side effect of slowing aging. AI would allow us to evaluate signals like this far more quickly and with far more confidence, potentially benefiting millions of people sooner.
AI Will Also Make Healthcare More Efficient and Less Expensive
Right now, doctors and nurses spend a vast amount of time writing to document patient encounters. Information is repeated, copied, and re-entered across systems. This is time taken away from actual care.
AI can reduce the burden of documentation, eliminate repeated information entry, and help ensure that critical details are captured accurately the first time. That creates enormous efficiency, reduces burnout, and lowers cost.
The goal is simple: more time for patients and better outcomes, without drowning clinicians in administrative work.
Anonymization Will Ironically Personalize Healthcare for Each Patient
There is a powerful irony here.
The anonymization of patient data and the use of AI will have the effect of dramatically personalizing healthcare for the individual patient.
At scale, AI can identify genetic and clinical traits that predict:
- Whether a patient is likely to respond to a therapy
- Whether a patient is likely to experience serious side effects
- Which dosage and treatment sequence is most likely to work
Treatments can be designed and administered explicitly for an individual patient rather than for a broad disease category.
With the analysis of extensive population data, brand new diseases and subsets of diseases, all with important treatment implications, will be identified by AI. This further personalizes care and makes it more effective.
AI Is Already Saving Lives With Limited Data
Even with today’s restrictions, AI systems are already proving what is possible.
- At Mayo Clinic, researchers have used AI to detect heart disease earlier by identifying subtle ECG patterns that cardiologists cannot see.
- DeepMind, working with the UK’s National Health Service, developed systems that can diagnose eye diseases and predict acute kidney injury up to two days before it occurs, giving clinicians critical time to intervene.
- At Massachusetts General Hospital, AI tools have flagged early-stage breast cancer in mammograms that were initially missed.
These are not hypotheticals. These are real patients, real diagnoses, real lives impacted.
And these systems are doing this with a fraction of the data that exists globally.
Now Ask the Obvious Question
If AI can already do this with limited, fragmented datasets, what happens when it can see the whole picture?
Imagine AI screening anonymized health data across entire populations and identifying:
- Early disease markers years before symptoms
- Which treatments lead to the longest and healthiest lives
- Why certain patients respond while others do not
- Hidden risk factors no one thought to look for
The speed of diagnosis would increase. The accuracy of treatment would improve. The suffering avoided would be enormous.
This is not incremental improvement. This is a structural shift in how medicine works.
Why Is This Not Happening Right Now?
This feels like a no-brainer. And yet here we are.
It is not because people disagree with the idea. Most do not.
It is not because anonymization is impossible. It is not.
It is not because AI is unproven. It is already working.
So why the delay?
- Because healthcare incentives reward caution, not progress.
- Because data control equals financial leverage.
- Because regulation punishes mistakes more than it values lives saved quietly.
- Because fear of what could go wrong outweighs urgency about what already is.
HIPAA was meant to protect patients. But in its current form, it is being used as a shield against action.
No one is explicitly saying no. Everyone is just waiting.
And people are dying while we wait.
A Brief, Honest Word on Privacy
Privacy matters. No one is arguing otherwise.
But anonymized data does not expose people. It protects them by learning from everyone.
We already accept managed risk in healthcare when the benefit is overwhelming. Vaccines, clinical trials, and public health surveillance all involve risk. We mitigate it. We do not freeze progress.
At some point, refusing to use safe, anonymized data stops being responsible and starts being harmful.
The Question We Keep Avoiding
If we can save lives without exposing identities, why are we not doing it?
Every year of delay means later diagnoses. Less effective treatment. Slower cures.
Those losses do not make headlines. But they are real.
The future of healthcare is not waiting on technology. It is waiting on permission.
And anonymizing healthcare data at scale may be the most obvious, life-saving decision we are refusing to make.
If that is not a no-brainer, it is hard to know what is.
Acknowledgment:
This article was developed with the insight and clinical perspective of Dr. Eric M. Mazur, an internist and hematology and oncology specialist who served as Vice President and Chief Medical Officer of Norwalk Hospital until his retirement in 2014. Dr. Mazur has been widely recognized for clinical excellence, leadership, and medical education, including designation as a Master of the American College of Physicians, and currently serves as Senior Physician Advisor to All Points Digital and volunteer teaching faculty at the University of Connecticut School of Medicine.
